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Abstract: Human adipose stem cells (hASCs) are promising candidates for cell-based therapies, but
they need to be efficiently expanded in vitro as they cannot be harvested in sufficient quantities.
Recently, dynamic bioreactor systems operated with microcarriers achieved considerable high cell
densities. Thus, they are a viable alternative to static planar cultivation systems to obtain high
numbers of clinical-grade hASCs. Nevertheless, the production of considerable biomass in a short
time must not be achieved to the detriment of the cells’ quality. To facilitate the scalable expansion
of hASC, we have developed a new serum- and xeno-free medium (UrSuppe) and a biodegradable
microcarrier (BR44). In this study, we investigated whether the culture of hASCs in defined serum-free
conditions on microcarriers (3D) or on planar (2D) cell culture vessels may influence the expression
of some marker genes linked with the immature degree or the differentiated status of the cells.
Furthermore, we investigated whether the biomaterials, which form our biodegradable MCs, may
affect cell behavior and differentiation. The results confirmed that the quality and the undifferentiated
status of the hASCs are very well preserved when they grow on BR44 MCs in defined serum-
free conditions. Indeed, the ASCs showed a gene expression profile more compatible with an
undifferentiated status than the same cells grown under standard planar conditions.
Keywords: serum- and xeno-free cell culture medium; UrSuppe; biodegradable microcarrier (MC);
biomaterial; human adipose stem cells (hASCs)
1. Introduction
Adipose tissue is remarkably understudied compared with other organs. However, in
recent years, due to increasing obesity and obesity-associated pathologies globally, this tis-
sue has gained significant attention from the research community. Now it is recognized as a
proper active endocrine organ at the center of energy balance and nutritional homeostasis,
mediating the regulation of multiple organs and tissue [1–3]. Adipose tissue’s developmen-
tal biology is beginning to be understood and has proved surprisingly complex [4]. These
studies have led to the discovery of several genes and proteins that regulate adipogenesis
that can now be used to assess the status of hASCs in culture.
The adipose tissue has been recently identified as a novel abundant source of adult
stem cells. A relatively noninvasive procedure, such as lipo-aspiration, gains access to
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the source tissue [5]. However, while being a rich source of stem cells, lipoaspirates
presently cannot provide enough cells for direct applications in regenerative medicine [6].
Several clinical studies with human adipose stem cells (hASCs) are very promising and
have reported that hASCs exerted beneficial effects in treating different disorders [7].
Human ASCs are increasingly in demand in plastic and reconstructive surgical procedures,
where we are witnessing a shift toward tissue-engineering strategies with stem cells [8].
Currently available reconstructive surgery employing synthetic materials or autologous fat
transplants is often disappointing due to volume maintenance’s long-term unpredictability.
Hence, the clinical use of hASC has spread throughout the world. Consequently, this
demand requires developing good manufacturing practices (GMP)-compliant ex vivo
expansion protocols to sustain the supply of safe and cost-effective clinical-grade cells.
Several published studies have recently shown that traditional, planar, and static
cultivation systems are not convenient to reach the high cell numbers required to implement
cell-based therapies. Therefore, at the moment, the most promising alternative to overcome
the drawbacks of planar static cultivation technologies are instrumented, stirred bioreactors
in combination with microcarriers (MCs) [9]. These are microspheres (with a diameter of
100–300 µm) composed of various materials, encompassing synthetic/organic or natural
polymers, manufactured with varying porosities and topographies. They furnish a surface
upon which anchorage-dependent cells can attach and subsequently grow in cell culture
medium by slow agitation [10].
When culturing stem cells in vitro, the amplification without affecting their “stemness”
and differentiation potentials is essential. Thus, the most obvious solution would be to
replicate the stem cell niche accurately. Unfortunately, reproducing this environment has
not been possible because most of the mechanisms ruling the stem cell fate in vivo are
yet not fully understood. Therefore, the cells are set to a “new” environment, defined
by two main components, which we can modify and adapt to their needs: one, the cell
culture medium and conditions, and two, the substrate where the hASCs grow. This “new”
environment might endanger the control of the cultured stem cells’ fate.
To overcome these hazards and ensure control over cell fate, we developed a defined
xeno- and serum-free medium, called “UrSuppe”, specially engineered to grow hASCs.
Fetal bovine serum (FBS) is still one of the prevalent ancillary materials used in cell culture,
although it is an incompletely characterized blend containing numerous growth factors
and hormones. Therefore, it is tough to control the stemness of the expanded hASCs in
this component’s presence [11]. Other, more classical, considerations apply to avoid FBS
in the cell culture medium used to grow therapeutic hASCs. Indeed, when FBS is used,
the risk of transferring zoonoses cannot be excluded. Furthermore, fetal bovine proteins
are internalized by the stem cells or stick on their surface, inducing an immune xenogenic
rejection upon autologous transplantation into the human patient [12]. Finally, except for
blood and endothelium, all the other cells in the tissues are usually never in direct contact
with serum. They are immersed or surrounded by the interstitial fluid, which has a lower
concentration of proteins than serum, and it is often distinct for each tissue or organ due to
a unique blend of secreted polypeptides and metabolic molecules. This is a situation that
we try to recreate and mimic in defined serum-free conditions. The same applies to the
platelet lysate (PL): despite being produced from human blood, it is a cocktail of numerous
growth factors and hormones, some of which with a well-known adipogenic promoting
activity, which acts in an unpredictable and uncontrolled way on the fate of the hASCs [13].
The control of stem cell fate, either in vivo or in vitro, has been ascribed mainly to
molecular or biochemical mediators, such as hormones, growth factors, or interactions of
extracellular matrix (ECM) ligands with cell surface receptors [14]. A variety of physical
signals from the environment also contribute to the cell stemness’ overall control. More
specifically, it is now known that the ECM geometry/topography at the nano-scale range,
the ECM biomechanical properties (e.g., elasticity versus stiffness), and the transmission of
mechanical (e.g., shear stress) or other biophysical factors to the (stem) cells may strongly
influence their fate [15]. Therefore, the substrate where the hASCs grow is the second
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principal component that we can fine-tune to transmit the appropriate cues to the cells and
represent a significant scientific challenge. We need to reproduce with biomaterials the
complexity of the ECM.
Currently, expansion protocols utilize planar static monolayer cell expansion in flask
or cell factories, but these systems are limited since they cannot reach hundreds of billions
of cells. However, in the field of regenerative medicine, this could barely satisfy one
treatment dose, and a patient may require multiple doses [16,17].
With this in mind, we also developed a new biodegradable microcarrier, named BR44,
tailored for the chemically defined cultivation of hASCs in dynamic systems. Biodegradable
MCs are advantageous as it is unnecessary to harvest the cells or use new scaffolds for cell
transfer. High cell viability and potency could be easily preserved with this MC type, sim-
plifying the downstream processing steps (DSP) when manufacturing therapeutic hASCs.
The criteria necessary to assemble a useful scaffold that mimics the biological microenviron-
ment (the cell “niche”) have not yet been fully understood. Therefore, the lack of specific
guidelines imposed to empirically verify each new scaffold’s suitability combined with
cells and the culture medium [18]. Therefore, in this study, we wanted to verify whether
hASCs growing on the biodegradable MC BR44 or the commercial non-biodegradable MC
ProNectin-F (PNF, Pall Solohill) preserve or not their undifferentiated status.
2. Materials and Methods
2.1. Microcarriers Production
The production of the microcarriers was extensively described in Muoio et al. [19].
Briefly, the manufacturing process relies on a double emulsion solvent evaporation tech-
nique where the most critical components for the manufacture are 17 KDa Poly(D, L-lactide-
co-glycolide) (PLGA) (lactide/glycolide ratio 50:50), Purasorb PDLG 5002 purchased from
Corbion Purac (Amsterdam, Netherlands). Polyvinyl alcohol (PVA, 87–89% hydrolyzed,
Mw 31 KDa) and methylene chloride from Merck (Darmstadt, Germany). Finally, porcine
gelatin, a generous gift from Italgelatine (Santa Vittoria d’Alba, Italy), and ammonium
hydrogen carbonate from Applichem (Darmstadt, Germany).
2.2. Extraction of Adipo-Cutaneous Tissue
The donors of the subcutaneous adipose tissue used in this study provided written
agreement as required from the local Ethics Committee of the Canton of Ticino, which
approved the project and its procedures (project reference number: CE 2915). The surgical
removal of adipose tissue was described by Panella et al. [19]. Adipose tissue samples were
stored at room temperature and processed at the latest 24 h after their collection [20].
2.3. Isolation and Culture of hASCs
2.3.1. Isolation of Stromal Vascular Fraction
Isolation of the cells of the SVF from human adipose tissue, in vitro culturing in
defined xeno- and serum-free conditions, cell cryopreservation, followed the ethical princi-
ples traced in the Declaration of Helsinki and according to the instructions of the Ethics
Committee of the Canton of Ticino (Switzerland). The protocol we routinely use to extract
the SVF is described precisely by Panella et al. [19]. We briefly summarize the essential
parameters here: the adipose tissue was homogenized in a blender then digested for 45 min
at 37 ◦C with 0.28 Wünsch Unit/mL of Collagenase AB (Worthington Biochemical Corp.,
Lakewood, NJ, USA). The addition of DPBS supplemented with 5% injectable human
albumin CSL (Behring AG, Bern, Switzerland) facilitated the separation of the aqueous
from the lipid phase. The aqueous phase cells were collected, filtered through sieve cell
strainers, and pelleted by centrifugation at 600× g for 10 min at room temperature. Finally,
the cell pellet was resuspended in DPBS with 1% injectable human albumin or in the tissue
culture medium.
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2.3.2. Characterization of SVF Cells by Flow Cytometry
Freshly isolated cells of the SVF were stained for analytical flow cytometry as described
by Panella et al. [19]. Briefly, the cells were incubated 20 min with the following monoclonal
mouse anti-human antibodies and fluorescent dyes: CD34-BV650, CD45-PC7, CD73-FITC
(BioLegend, San Diego, CA, USA), CD146-PE, CD36-APC (Miltenyi BioTech, Bergisch,
Germany), 7-amino-actinomycin D (7-AAD) (Becton Dickinson, Franklin Lakes, NJ, USA),
and Syto40 (Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA). After that,
the erythrocytes were lysed with 200 µL of VersaLyse solution (Beckman Coulter Inc.,
Pasadena, CA, USA). ASCs are described as CD45-, CD146-, CD36-, CD34+, and CD73+
cell populations. Samples were acquired according to our flow cytometer procedure. More
details about this protocol can be found in the Supplementary Materials Table S1, which
accompanies and complements this study.
2.3.3. Flow Cytometer Procedure
The CytoFLEX Flow Cytometer was used to acquire the raw data analyzed using
the Kaluza software (both from Beckman Coulter Inc., Pasadena, CA, USA). Spill-over
coefficients were established employing single-stained control particles (VersaComp An-
tibody Capture Bead Kit, Beckman Coulter) or appropriately single-stained cells. The
compensation matrix was worked out using the dedicated function of the Kaluza software.
Optical alignment and fluidics were periodically monitored using flow-check fluorospheres
(CytoFLEX Daily QC Fluorosphere, Beckman Coulter, Brea, CA, USA).
2.3.4. Initial Seeding of the SVF Cells and Cell Passaging
After the adipose tissue extraction, hASCs were cultured right away only in our
proprietary defined serum- and xeno-free cell culture medium called UrSuppe. This latter
was developed to culture hASCs and could be produced under GMP conditions. It contains
exclusively pure molecules, some recombinant human growth factors, and injectable
human albumin in the µg range. After the characterization of SVF cells by flow cytometry,
hASCs were plated at a density of 30,000–50,000 hASCs/cm2 in fibronectin-peptide pre-
coated cell culture vessels (Corning PureCoat™ ECM Mimetic Fibronectin Peptide, Corning
Inc., Corning, NY, USA). The medium was replaced every 2 days, keeping 50% of it, until
the cells were between 80% and 90% confluent. In the Supplementary Information of
Panella et al. [19], we describe in detail the initial plating of the cells (Section 3), and
we give some suggestions on how to work in defined serum-free conditions (Section 4).
For passaging, the cells were detached with TrypLETM Select (Life Technologies, Thermo
Fisher Scientific, Waltham, MA, USA) after 2 min of incubation at 37 ◦C. The hASCs were
washed with DPBS at least once to remove the protease, counted, resuspended in UrSuppe
medium, and finally seeded in new cell culture vessels (Corning PureCoat™ ECM Mimetic
Fibronectin Peptide, Corning Inc., Corning, NY, USA) at a density of 10,000 hASCs/cm2.
2.4. Cells Seeding on MCs for Static Experiments
Protocol for efficient seeding of hASCs on the microcarriers we used for the exper-
iments: (A) Cell preparation procedure: After detachment, the cells were washed with
DPBS supplemented with 1% human albumin, counted with Trypan Blue (Life Technolo-
gies, Thermo Fisher Scientific, Waltham, MA, USA), and resuspended in UrSuppe medium
at a concentration of 280,000 cells/µL. (B) Preparation of the positive control MC: The
lyophilized PNF MCs (Pall SoloHill, Port Washington, NY, USA) were incubated in UrSuppe
medium for 1 h at 37 ◦C in agitation. (C) Preparation of the test MCs: The BR44 prototype
manufactured by Sferalp SA (Monteggio, Switzerland) was washed in DPBS and then
incubated in UrSuppe for 1 h at 37 ◦C in agitation and finally washed with DPBS again.
Just before the tests, the MCs were resuspended in 250 µL UrSuppe. The surface area
available for cell adhesion was 2.5 cm2 (PNF) or 1 cm2 (BR44). Adhesion and proliferation
assays of hASCs growing on MCs were performed in vessels developed to avoid the cells’
attachment to the plate surface (Ultra-Low Attachment surface, Corning Inc., Corning, NY,
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USA). A total of 250 µL of MCs suspension were seeded in each well and gently mixed to
distribute the carriers. Then, 250 µL of ASCs suspension were added, drop by drop. After
gently mixing, the plate was put in the incubator (37 ◦C, 5% CO2), and the hASCs were
cultured for 7 days. Every 2 days, half of the medium was removed and replaced with a
fresh one.
2.5. Attachment and Growth of hASCs in Static Conditions
2.5.1. Cell Adhesion—Nuclei Analysis
Nuclei staining is a reliable approach to assess cell density during the microcarriers-
based culture of adherent cells. After 2–4 days of growth, the carrier-cell aggregates
were fixed (30 min on ice) with a DPBS solution containing 2% formaldehyde and 0.2%
glutaraldehyde (both from Sigma-Aldrich Inc., St. Louis, MO, USA). The samples were
washed two times with DPBS, resuspended in DPBS containing 500 nM DAPI (Sigma-
Aldrich Inc., St. Louis, MO, USA), and finally incubated for 20 min in the dark at room
temperature. After that, the samples were washed twice with DPBS, and the carrier-
cell aggregates were resuspended in 85% glycerol solution and mounted for microscope
inspection. Images were acquired with a UV laser (405 nm) on an inverted fluorescence
microscopy Nikon Eclipse Ti (Nikon, Minato, Tokyo, Japan).
2.5.2. Cells Adhesion—Scanning Electron Microscope (SEM) Analysis
After 2–4 days of growth on the MCs, the carrier-cell aggregates were fixed with a 3%
glutaraldehyde solution for 30 min on ice. Next, the aggregates were washed twice with
DPBS, resuspended in distilled H2O, and let completely dry on a metal stub at RT for 3 h.
Finally, the samples were coated with gold/palladium in a Mini Sputter Coater at 18 mA
for 60 s and analyzed with a TM3030 Hitachi microscope (Tokyo, Japan) at 15 kV.
2.5.3. Analysis of Nuclei Released from hASCs Grown on MCs by Flow Cytometry
The proliferative status of hASCs grown on MCs was investigated by analyzing
samples taken on different days. The full protocol for the nuclei extraction from hASCs
grown on MCs is reported in the Supplementary Materials that accompanies and completes
this article, paragraph “Evaluation of cell proliferation” and Figure S1. After the extraction,
the nuclei were stained with 1.25 ng/µL of 7-AAD and analyzed by flow cytometry using
the CytoFLEX Flow Cytometer manufactured by Beckman Coulter Inc. The acquired data
were elaborated with the Kaluza software (Beckman Coulter Inc., Brea, CA, USA). The
gating strategy to exclude debris and aggregates has been explained in Muoio et al. [21] in
the Supplementary Materials Figures S8 and S9.
2.6. Evaluation of Cellular Phenotype
2.6.1. Cell Detachment and Harvesting from the MCs for Flow Cytometry or RT-qPCR Analysis
To detach the hASCs from the MCs, the carrier-cell aggregates were transferred into a
15 mL tube and digested for 10 min at 37 ◦C with TrypLETM Select (ThermoFisher Scientific,
Waltham, MA, USA) by gentle agitation. After washing away the protease with DPBS/1%
injectable human albumin, the hASCs were separated from the MCs by filtering the mixture
through a pluriStrainer Mini 40 µm mesh sieve (PluriSelect life science, Leipzig, Germany).
The cell suspension was centrifuged at 400× g for 5 min. The pellet was resuspended in
FACS buffer (DPBS supplemented with 1% injectable human albumin and 50 ng/µL human
immunoglobulins, Privigen Immunoglobulin, CSL Behring AG, Bern, Switzerland) for
flow cytometry analysis, or left as a pellet for total RNA extraction and RT-qPCR analysis.
2.6.2. Flow Cytometry Analysis of hASCs Grown on Cell Culture Vessels or MCs
Each assay contained a unique combination of the following mouse anti-human
monoclonal antibodies: CD73-FITC, CD90-APC, CD105-PE (BioLegend, San Diego, CA,
USA), CD34-PE, CD36-APC, CD146-PE (Miltenyi BioTech, Bergisch, Germany), CD61-PE
(Beckman Coulter Inc., Pasadena, CA, USA), CD15-FITC, and 7-AAD (Becton Dickinson,
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Franklin Lakes, NJ, USA). All antibodies were titrated and used at a 50 ng/assay concentra-
tion. Isotype controls and specific mAbs were employed at the same final concentrations.
Routinely, 50,000 hASCs (in 100 µL FACS buffer) were mixed with the appropriated an-
tibody combination and incubated for 15 min at RT in the dark. Finally, the sample was
diluted with 100 µL FACS buffer before the acquisition, according to our flow cytometer
procedure (see Section 2.3.3).
2.6.3. RT-qPCR Analysis
According to the manufacturer’s instructions, RNAs were extracted from cell pellets or
carrier-cell aggregates employing the Nucleospin®RNA kit (Macherey-Nagel, Düren, Germany).
The kit’s purification procedure foresees an on-column digestion step with DNase I. RNA purity
and quantity were evaluated with the NanoDrop device (Thermo Fisher Scientific, Waltham,
MA, USA). Total RNA integrity was periodically checked by conventional agarose gel elec-
trophoresis. Typically, 400 ng of RNA were transcribed into cDNA by the reverse transcription-
polymerase chain reaction performed by the commercial kit “GoScript™ Reverse Transcription
System” (Promega, Madison, WI, USA). This reaction is summarized in the Supplementary
Materials Table S2. The genes SOX9, RUNX2, PPARG, PREF1, ZFP423, ZFP521, and DKK1
were subjected to RT-qPCR using the “SsoAdvanced Universal SYBR® Green Supermix” kit
(Biorad, Hercules, CA, USA), and the results detected with the “CFX Connect Real-Time PCR
Detection System” (Biorad, Hercules, CA, USA). For each gene under investigation, RT-qPCR
was performed with 20 ng of cDNA. ACTB was employed as an internal control. Each primer
pair product was checked for proper amplification by agarose gel electrophoresis. We used
exclusively primer pairs, which gave rise to single sharp bands of the expected size. Primer
sequences, temperatures, and cycle conditions are shown in the Supplementary Materials
Tables S3 and S4. Data were analyzed with the CFX software to calculate the relative fold gene
expression using the formula 2−∆∆Ct.
2.7. Proof-of-Concept Cultivation in Spinner Flasks
Proof-of-concept cultivation was performed for one donor (n = 1) with the BR44 MC
in a disposable Corning spinner flask (working volume = 100 mL). The spinner flask was
inoculated with an initial cell density of 20,000 cells/cm2 (=38,794 cells/mL) and with 5 g/L
(≈194 cm2) of the BR44 MC. The MC concentration and cell-to-bead ratio for the inoculation
were defined based on previous cell attachment studies performed in well plates (data not
shown). The cell inoculum was prepared in T75-flasks coated with Synthemax II coating
(Corning Inc.) and with cells from P1. Before inoculation, the MCs were equilibrated in the
UrSuppe cell culture medium for up to 12 h. A static cell attachment phase was performed
for 24 h in a cell culture incubator (37 ◦C, 5% CO2, 80% rH). After the cell attachment,
the cell culture was continuously stirred at 55 rpm. A partial medium exchange of 30%
(no MC feeds) was performed on day 5. Offline samples were taken daily to measure
substrate and metabolite concentrations (Glc, Lac, Amn, San Diego, CA, USA) with a Cedex
Bio (Roche Diagnostics, Rotkreuz, Switzerland). The hASC cell number was measured
using a NucleoCounter NC-200 (ChemoMetec, Allerod, Denmark) combined with the
Via-1-cassette. In addition to the cell measurements, 1 mL of the MC-cell suspension was
fixed after sampling with a 3% PFA solution for DAPI staining. Based on the cell-specific
values, growth-related parameters were calculated according to the equations indicated in
the Supplementary Materials; see the paragraph “Evaluation of growth-related parameters”.
2.8. Biochemical Analysis
2.8.1. Proteome Profiler Array
The conditioned medium from cell grown in planar, static 3D, and 3D dynamic con-
ditions, were investigated to monitor selected secreted polypeptides. Human ASCs of
the three tested cell culture systems were left with the same medium for 7 days before
collecting the supernatants. These latter were initially filtered through 0.22-micron Syringe
Filters (Jet Biofil, Guangzhou, China) to remove the particulate. Next, 1 mL of each su-
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pernatant was poured onto a nitrocellulose membrane containing many different capture
antibodies and left overnight by gentle rocking. According to the instructions provided
with the “Proteome Profiler Human Adipokine Array Kit” (R&D Systems, Minneapolis,
MN, USA), all subsequent manipulations were undertaken. The secondary biotinylated
detection antibodies were highlighted by the use of Streptavidin conjugated IRDye 800 CW
(Li-Cor Corporate, Lincoln, NE, USA). Positive signals were detected after scanning the
membrane with an Odyssey®CLX Imaging System (Li-Cor Corporate, Lincoln, NE, USA).
Data were elaborated using Li-Cor software to evaluate the signal intensity ratio between
the different adipokine spots and the positive control reference spot.
2.8.2. Amino Acid Analysis
The conditioned media from cells grown in standard planar 2D, static 3D, and dy-
namic 3D conditions were analyzed according to Bidlingmayer et al. [22] to determine the
amino acid concentration in the supernatants. Coupling reaction: 10 µL of each sample were
pipetted in a glass tube (5 × 60 mm) with 5 µL EDTA-solution and dried on a vacuum
concentrator (Speedvac). Then 10 µL of Coupling Solution A (MeOH/H2O/Triethylamine
(2:2:1)) were added and dried again on a vacuum concentrator. The samples were redis-
solved in 10 µL Coupling Solution B (MeOH/H2O/Triethylamine/Phenylisothiocyanate
(70:10:10:1)), incubated for 20 min at RT, and dried for 30–45 min. Standard: Refer-
ence solutions of L-Alanyl-L-Glutamine, L-Glutamine, Trans-4-Hydroxy-L-Proline, and
L-Tryptophane, were prepared at a concentration of 2.5 µmol/µL in 0.1% HCl. To 50 µL
of the amino acid standard H (Thermo ScientificTM PierceTM, 2.5 µmol/µL each), 50 µL
of each amino acid reference solution were added and diluted to 1 µL with 0.1 M HCl
(=125 nmol/µL each). Then, 10 µL of this standard solution was treated as described before
(see Coupling reaction). Analysis: The samples were reconstituted in 50 µL ammonium
acetate buffer pH 6.4 containing 4% acetonitrile (HPLC eluent [A]). Injection volume: 20 µL;
Standard = 500 pmol/AS (except Cystine = 250 pmol). HPLC: Column: Waters Nova-Pak
C18, 4 mm, 60 A, 3.9 × 125 mm. Device: Thermo Ultimate-3000, UV detection at 247 nm,
and column temperature 50 ◦C. Eluent A: 96% 0.14 M Ammonium acetate, 575 µL Triethy-
lamine PH 6.4. Eluent B: 40% H2O Milli-Q, 60% Acetonitrile. Gradient: 3% [B] to 50% [B]
in 12 min.
2.9. Statistical Analysis
Statistical analyses were performed using SPSS (IBM, Armonk, NY, USA) or Prism
7 (Graph Pad Software Inc., San Diego, CA, USA). The assumption of the analysis was
checked: normal distribution and homogeneity of the variance. p-values lower than 0.05
were considered statistically significant. The differences between groups for cellular growth
on the MCs were evaluated with a two-way repeated-measures ANOVA. The differences
between groups for flow cytometry and gene expression profile were evaluated with a
one-way ANOVA.
A list of the materials used in this study, which complements the information given in
this section, can be found in the Supplementary Materials Table S5.
3. Results
3.1. Properties and Stability of Microcarriers
The BR44 manufacturing process consists of a double emulsion, solvent evaporation
system, generating a blend of poly lactic-co-glycolic acid (PLGA) and porcine gelatin.
Scanning electron microscopy (SEM) of the BR44 showed an excellent regularity of this
MC’s shapes and size based on resorbable and biodegradable biopolymers. Structurally,
the microcarrier has a spherical shape, reticulated frame, and a very porous consistency,
also internally (Figure 1(A1–A3)). We used the ProNectin F (PNF) MC as a positive control
for our tests. This bead performs well in defined serum-free media, like the UrSuppe
cell culture medium [23]. PNF MC consists of a synthetic core bead (polystyrene) with
a thin layer of recombinant, non-animal source polymer on its surface that incorporates
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multiple copies of the RGD attachment signal sequence of the human fibronectin protein.
The microphotographs show a very regular shape and size, with internally a solid and
compact construction (Figure 1(B1–B3)). However, the coating is not evenly distributed on
the carriers’ surface but instead with a spotted pattern (Figure 1B). On the other hand, the
gelatin coating of BR44 MC is homogeneously distributed inside and on the microsphere’s
surface, as shown by Muoio et al. [21].
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We checked the stability of BR44 MC in an aqueous solution. It is essential to verify that
the microspheres are stable at 4 ◦C for a significant time. At the same time, biodegradability
should occur at 37 ◦C, with the usual parameters used to cultivate cells. We found that
the BR44 was stable in water at 4 ◦C for up to 2 months, and no signs of degradation
were observed (Figure 2). The biodegradability and other bioengineering parameters
(size variation/shape variation and sedimentation velocity) of BR44 MC were evaluated
and described by Muoio et al. [21]. Figure 3 shows the change in the shape of BR44
MCs under stirred conditions at 37 ◦C after 1, 4, and 9 days, respectively, confirming the
carrier’s erodibility.
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3.2. Static Investigations: Cell Adhesion and Proliferation on MCs
MC prototypes were manufactured and evaluated for their capacity to permit the
adhesion of hASCs under serum- and xeno-free conditions. We found that the BR44 MC
prototype promoted cell attachment and proliferation comparable to a commercial product,
PNF MC. Figures 4 and 5 show the efficient attachment and growth hASCs on the BR44
MC compared to the PNF MC.
After few days of culture in static conditions, the MCs are completely colonized by
cells. We observed large aggregates’ formation confirming the suitability of BR44 as a
three-dimensional scaffold to grow primary cells in serum and xeno-free conditions. PNF
MC also performed very well, and the cells colonized it quickly, efficiently, and entirely as
shown in Figure 4B. However, we noticed that with PNF MC, the formed aggregates’ size is
smaller than that observed when using BR44 MC. Thus, for reasons currently unknown, the
BR44 MC-based culture system appears to be “stickier” than that dependent on PNF MC.
It is often difficult to detach with high yield cells from the MCs they have grown
on. For this reason, we developed a procedure based on nuclei count: A cell lysis buffer
solution frees the nuclei that can be enumerated by flow cytometry. This method also
allows assessing the cell cycle status of the collected nuclei. Therefore, it is also possible
to determine the proliferative status of the hASCs grown on the BR44 MC or PNF MC
(for more information, see the “Materials and Methods” section, Section 2.5.3 “Analysis of
nuclei released from hASCs grown on MCs by flow cytometry”). As shown in Figure 6,
although the BR44 MC prototype does not usually reach active proliferation rates greater
than or equal to PNF, the results obtained, compared to the “top of the class,” are all very
remarkable. Thus, we can conclude that BR44 MC allows hASCs to adhere on its surface
and maintains a significant percentage of cells in active proliferation in static conditions
during the 7 days analyzed in these experiments.
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3.3. Flow Cytometry Analysis of Some Standard Markers in Static Conditions
It is very important to certify that the hASCs growing on BR44 MC (static 3D condi-
tions) exhibit the same standard surface markers and preserve an immature status as the
same batch of cells cultivated in traditional cell culture vessels (2D conditions). After 7 days
of culture, flow cytometry analysis of these surface proteins highlighted some notable
distinctions between cells grown in 2D from those grown in 3D on BR44 MC or PNF MC
(see Figure 7). The canonical markers [5] CD73 and CD90 showed no differences in the
J. Funct. Biomater. 2021, 12, 25 12 of 28
three conditions tested. However, with PNF MC, the number of CD105 positive hASCs
was lower (statistically significant result). A second substantial difference concerned the
CD146 marker, whose expression decreased on MCs. This cell surface marker protein is
associated with adipogenic differentiation. Indeed, Graham G. Walmsley et al. showed that
hASCs induced to differentiate into adipocytes expressed the CD146 as well as the CD36
markers [24]. Therefore, these observations lead us to consider as a positive factor the
decrease in the number of positive CD146 hASCs observed when the cells were cultured
on MCs (statistically significant result). The most significant decrease was observed in
combination with the PNF MC. This suggests that the type of MC used for the culture can
shape the cells’ phenotype.
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CD61 is a control marker related to the cells’ undifferentiated status and is not ex-
pressed by human fibroblasts [25]. The cells we analyzed are practically 100% positive for
this marker, so the cultures do not appear to be contaminated with fibroblasts. The low per-
centage of CD15+ or CD34+ is an excellent feature of the hASCs grown in UrSuppe medium,
which signalize being mostly immature cells. Taken together, the hASCs grown on MCs do
not degenerate and maintain their undifferentiated status, at least as well as those cultured
in standard cell culture vessels. This consideration is also supported by the low percentage
of CD36 positive cells, an established marker for ongoing adipogenesis [26–28].
3.4. Proof-of-Concept Cultivation in Small Scale Spinner Flasks
Figure 8A,B shows the time-dependent profiles of the cell density and the sub-
strate/metabolite concentrations during the proof-of-concept cultivation in a spinner
flask with the BR44 MC. After 24 h cell attachment phase, an attachment efficiency of
188% was achieved. This result indicates that a significant number of the cell population
had already started to divide within the static cell attachment phase. A peak cell density
of 1.78 × 105 hASCs/cm2 (=3.18 × 105 hASCs/mL) was achieved on day 10. Due to the
“natural” stickiness of biopolymers (e.g., gelatin), BR44 MCs tend to aggregate early during
the cultivation, which affected the sampling. A maximum expansion factor of 8.1 was
achieved on day 10. The hASCs grew at a specific growth rate of 0.25 d−1 (->td = 67.2 h).
Based on the calculated growth-dependent parameters, cell growth was simulated accord-
ing to our unstructured, segregated growth model [23,29]. The deviations between the
experimentally measured and simulated cell densities were mainly due to the stickiness of
the BR44 MC and the more difficult sampling. However, the proof-of-concept cultivation
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results demonstrate the growth of hASCs on BR44 MCs under dynamic conditions. The
growth parameters of BR44 are summarized in Table 1.




Figure 8. Time-dependent profiles of cell density (A), substrate/metabolite concentrations (B), and DAPI stained micro-
scopic pictures during the proof-of-concept cultivation in the spinner flask (C). A partial medium exchange of 30% was 
performed on day 5. The symbols represent the experimentally measured values collected from offline measurements. 
The lines represent the simulated time courses, which were calculated according to [23]. Scale bar for fluorescence micro-
scopic pictures = 650 μm. 
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Tabl 1. Growth paramet rs of BR44 in Spinner flask culture.
Parameter µ td Atteff Xmax EF YLac/Glc qGlc qLac qAmn
(d−1) (d) (%) (105 cells/mL) (-) (mmol/mmol) (pmol/cell/d) (pmol/cell/d) (pmol/cell/d)
BR44 0.25 2.8 188 3.18 8.1 2.6 3.60 10.01 1.87
µ: specific cell growth rate. td: doubling time of cell population. Atteff: attachment efficiency. Xmax: maximum cell concentration on the
planar growth surface. EF: expansion factor. YLac/Glc: lactate yield per glucose equivalent. qGlc: specific glucose consumption rate. qLac:
specific lactate production rate (growth-dependent). qAmn: specific ammonium production rate (growth-dependent).
During the cultivation, glucose concentration decreased to a minimum value of
15.15 mmol/L, demonstrating that glucose was not a limiting factor. As a result of glucose
metabolism, lactate concentration increased to a maximum value of 7.77 mmol/L, which
resulted in a YLac/Glc of 2.6. This high YLac/Glc value indicates that additional Lac might be
released from the MCs during the cultivation because the maximum values of 2 for YLac/Glc
can be expected from the glycolysis pathway. The ammonia concentration remained at
0.99 mmol/L, relatively low during the entire cultivation. Consequently, both lactate and
ammonia levels were below critical concentrations (Laccrit ≈ 35 mM, Amncrit ≈ 2.4 mM)
described in the literature [10,30–33].
Figure 8C shows microscopic fluorescence pictures of DAPI-stained hASCs on BR44
MC during the spinner flask cultivation. It is recognizable that the aggregate size increased
as a function of the cell density. Already on day 3, the first MC-cell-aggregates were visible.
On day 9, most of the MCs were part of MC-cell-aggregates, which were highly confluent.
3.5. Gene Expression Survey by RT-qPCR of Some Essential Factor Regulati g Adipogenesis
With these experiments, we wanted to verify whether the cell culture methods influ-
enced the marker genes’ expression we selected for this assay. ASCs obtained from three
different donors were cultured with UrSuppe medium in four separate ways: 1. In standard
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static cell culture vessels (2D). 2. On BR44 MC in static conditions. 3. On PNF MC in
static conditions. 4. On BR44 MC in dynamic conditions. RT-qPCR was used to measure
the expression level of the marker genes depicted in Figure S7. The normalized values
obtained were related to those acquired from hASCs grown in static 2D conditions, and the
final data visualized with three histograms, as shown in Figure 9A–C. Among the essential
genes linked with the undifferentiated status of hASCs, there are PREF1 [34], ZFP521 [35],
and SOX9 [36], whereas PPARG [37], ZFP423 [38], and DKK1 [39,40] are known adipogenic
commitment and lineage differentiation factors (for review see [41]). RUNX2 [42] was
included in the test panel to check whether the hASCs accidentally differentiated towards
a chondrogenic or osteogenic lineage. As shown in Figure 9A–C, the relative expression
levels of PREF1, the seal of the undifferentiated status of hASCs, were higher in all 3D
conditions. However, only for the cells grown on BR44 MC in dynamic conditions, the
increase of PREF1 was statistically significant. The same trend was also observed, slightly
increase or no change, with the other markers signalizing an immature state of the cells,
i.e., ZFP521 and SOX9 (exception in 8B with a decrease). In parallel, the relative expression
level of PPARG, the master regulator of adipogenesis, slightly decreased in all 3D condi-
tions tested. The other prodifferentiation markers also followed this trend, i.e., ZFP423 and
DKK1, as shown in Figure 9A,C. Instead, for the cells cultured in 3D on PNF MC, these two
genes’ relative expression levels slightly increase (Figure 9B). Finally, the value of RUNX2
slightly decreased or remained unchanged, indicating that the hASCs grown in 3D do not
randomly differentiate into chondrocytes or osteocytes. Therefore, since no statistically
significant differences between genes involved in hASCs differentiation were observed, we
concluded that the undifferentiated status of hASCs is preserved very well when they grow
on MCs in defined serum-free conditions. However, this profile worsens with increasing
cell density [23]. Therefore, an important goal for the future will be to learn how to culture
hASC on MC and maintain them at the ideal density to keep their undifferentiated status
until harvest or other downstream processes. In conclusion, hASCs grew very well on
the biodegradable BR44 MC in a static or dynamic cell culture system combined with the
defined UrSuppe medium.
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To determine the presence of 58 human adipokines, we employed a commercially 
available “Proteome Profiler Human Adipokine Array” kit (see Table 2, Figure 10, and 
Supplementary Materials Figure S8). Thus, we decided to challenge the results obtained 
previously by flow cytometry and RT-qPCR by analyzing the hASCs cultured under de-
fined conditions on MC with a completely different technique, i.e., the study of the poly-
peptides secreted by these cells. Interpreting and making biological sense for a proteome 
profiler array is very complicated, especially when many secreted factors are detected. 
Fortunately, our case was not too complex and allowed us to notice patterns that could 
help interpret the results. Thus, we realized that the detected factors could be classified 
into six categories. Furthermore, they were all polypeptides associated with the adipose 
tissue (for review, see [43]). As a first very positive result, we found that two signature 
adipokines (adiponectin and leptin, reviewed in [44]), typical for mature cells, were not 
detected. Moreover, the signal corresponding to Nidogen/Entactin, a sulfated mul-
tidomain glycoprotein component of basement membranes, was reduced and feeble when 
the cells were grown in dynamic 3D conditions. 
In this assay, we noticed that IGFBP-4 is not present in the supernatant of hASCs 
cultured in dynamic 3D conditions, and besides, IGFBP-6 is reduced compared to the 
other two conditions. On the other hand, IGFBP-7 secretion was higher when the hASCs 
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Figure 9. Relative expression levels of some genes regulating the adipocyte differentiation process measured by RT-qPCR.
Primary hASCs from three different donors were grown in standard 2D cell culture vessels, in static 3D cell culture system
on BR44 MC (A), in static 3D cell culture system on PNF MC (B), and in dynamic 3D cell culture system on BR44 (C). The
calculated expression levels of the different markers for the 3D tests are related to the values obtained in the 2D conditions.
(n = 3 error bars represent S.E.M.). * Statistically significant: p-value < 0.0001.
3.6. Investigating the Secretome Profile of hASCs Cultured in Standard Static 2D vs. Static or
Dynamic 3D Conditions
To determine the presence of 58 human adipokines, we employed a commercially
available “Proteome Profiler Human Adipokine Array” kit (see Table 2, Figure 10, and
Supplementary Materials Figure S8). Thus, we decided to challenge the results obtained
previously by flow cytometry and RT-qPCR by analyzing the hASCs cultured under defined
conditions on MC with a completely different technique, i.e., the study of the polypeptides
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secreted by these cells. Interpreting and making biological sense for a proteome profiler
array is very complicated, especially when many secreted factors are detected. Fortunately,
our case was not too complex and allowed us to notice patterns that could help interpret
the results. Thus, we realized that the detected factors could be classified into six cate-
gories. Furthermore, they were all polypeptides associated with the adipose tissue (for
review, see [43]). As a first very positive result, we found that two signature adipokines
(adiponectin and leptin, reviewed in [44]), typical for mature cells, were not detected. More-
over, the signal corresponding to Nidogen/Entactin, a sulfated multidomain glycoprotein
component of basement membranes, was reduced and feeble when the cells were grown in
dynamic 3D conditions.
Table 2. Simple qualitative evaluation of the factors secreted by hASCs grown in three systems: standard 2D cell culture
system, static, or dynamic 3D conditions. The qualitative evaluation for each detected factor is indicated by the number
of X. Shallow expression is indicated by (X), whereas no expression by (-). The UrSuppe medium was employed in all
conditions tested. Quantitative results are shown in Figure 10. For more details, see Supplementary Materials Figure S8 and
Tables S9 and S10.





Cathepsin D X XX XXAspartyl- and
cysteine-proteases Cathepsin L X XX X
Insulin-like growth
factor binding proteins
IGFBP-4 XX X (-)
IGFBP-6 X XXX (X)
IGFBP-7 X XXX XX
CXCL8/IL-8 XXX XXX (X)
CCL2/MCP-1 X X X
M-CSF X (-) X
MIF (X) XXX XXX
IL-6 (X) XX XXX
Pentraxin-3/TSG-14 XX XXX X
Cytokines, chemokines,
inflammatory factors
Complement Factor D X XXX (-)
Extracellular matrix Nidogen-1/Entactin XX XXX X
Metalloproteases
inhibitor TIMP-1 XX X XXX
Angiogenesis and cell
proliferation
HGF XX (X) X
VEGF (-) X (-)
In this assay, we noticed that IGFBP-4 is not present in the supernatant of hASCs
cultured in dynamic 3D conditions, and besides, IGFBP-6 is reduced compared to the other
two conditions. On the other hand, IGFBP-7 secretion was higher when the hASCs were
cultured on BR44 MC, whereby static 3D was better than dynamic 3D. Compared to the
standard 2D cell culture system, we consider its upregulation in both 3D conditions as an
interesting and positive phenomenon.
The protein microarray used in this study evidenced the presence of several cy-
tokines [45] and chemokines [46] in the tested media: CXCL8/IL-8, CCL2/MCP-1, M-CSF,
MIF, IL-6, PTX3/TSG-14, and Complement Factor D. It is challenging to find a common
denominator for these secreted factors, which are primarily associated with an inflam-
matory condition. However, we noted some differences depending on the cell culture
conditions. The expression of IL-6 is low in the conditioned media of cells grown in 2D,
whereas higher in those from the 3D conditions (dynamic > static). IL-6 is a pleiotropic
cytokine and takes on essential tasks in immunity, tissue regeneration, and metabolism [47].
Like several other inflammatory cytokines, it is an inhibitor of adipogenesis and blocks
adipocyte differentiation [48]. Recently, it was shown that IL-6 mediates white adipose
tissue browning [49]. Therefore, this cytokine plays an important regulatory role in adipose
tissue, and much of these effects have yet to be understood. Since IL-6 is an antiadipogenic
factor and plays a role in angiogenesis [21], the increase in its secretion under dynamic 3D
conditions could be considered positive as it would help avoid unwanted spontaneous
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differentiation into adipocytes of cultured hASCs. Regarding IL-8, it is high in 2D and
static 3D conditions, whereas very low in the dynamic 3D cell culture system. Pentraxin
3 (PTX3), also called tumor necrosis factor (TNF)-inducible gene 14 protein (TSG-14), is a
pattern recognition molecule that acts in innate immunity and is a valuable biomarker of a
proinflammatory status [50]. This factor was promptly found in the supernatants of cells
cultured in 2D and static 3D, but was lower in dynamic 3D conditions. The adipose tissue
produces complement components that play nonimmunogenic roles [51]. Indeed, it was
shown that Complement Factor D promoted adipocyte differentiation [52]. In our analysis
Complement Factor D was expressed only in static 3D conditions. In 2D it was very low,
whereas, in dynamic 3D conditions, it was not detected. Finally, MCP-1 was expressed
similarly in all conditions tested as well as M-CSF, albeit at moderate levels.
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In our study, TIMP-1 expression is higher in the supernatants of hASCs grown on
BR44 MC under dynamic 3D conditions than standard 2D culture systems and 3D static
conditions. We evaluated this result positively, marking one more point in favor of the
BR44 MC and the defined dynamic 3D cell culture system. Finally, in the cell culture
supernatants, we also detected two factors related to angiogenesis and cell proliferation:
Vascular Endothelial Growth Factor (VEGF, reviewed in [53]) and Hepatocyte Growth
Factor (HGF, reviewed in [54]). The first one was detected only in the conditioned media
of hASCs cultured in static 3D conditions. In contrast, the second one was present in the
supernatants of hASCs grown in standard 2D cell culture vessels but very low in both
3D cell culture conditions. Table 2 qualitatively displays the results obtained for each
detected factor and catalogs them according to six biological characteristics to facilitate the
comparison of the three secretion profiles. A careful analysis of this table’s trends suggests
that antiadipogenic factors increase while adipogenic and inflammatory factors decrease
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in dynamic 3D conditions. These observations are in line with the results obtained by
RT-qPCR and flow cytometry.
3.7. Comparing the Amino Acid Consumption between hASCs Cultured in a Standard 2D System
with Those Grown in Dynamic 3D Conditions on BR44 MC
We reasoned that free AAs in hASCs culture media could provide valuable informa-
tion on cell metabolism and obtain information on their status by comparing the AAs
consumption profile obtained with cells grown in static 2D with cells cultured in dynamic
3D conditions (see Figure 11). Furthermore, this analysis may reveal limiting nutrients
that may inhibit cell growth, thus indicating how to improve the cell culture medium’s
performance. As shown in Figure 11, the amino acid consumption of hASCs grown in
dynamic 3D conditions was monitored with samples taken on days 1, 3, 5, and 9. Instead,
the consumption in standard 2D conditions was determined on day 5. As a first observa-
tion, we noticed that amino acids’ trends and consumption patterns are similar between
the standard 2D system and the dynamic 3D conditions. We consider this an excellent
result, which indicates, once more, that hASCs grown in dynamic 3D conditions do not
degenerate and maintain characteristics similar to those of cells cultured with traditional
2D static systems.
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The amino acid consumption profile in Figure 11 shows that the essential AAs are
generally consumed during the cell cultivation period, in both planar 2D and dynamic
3D conditions in a similar way. Some of the nonessential amino acids are, in reality,
essential for synthesizing nucleotides (glycine, aspartate, and glutamine). However, their
concentration does not matter as it remains constantly higher than the initial one or
drops slightly at the end of the cultivation period (Asp, day 9, dynamic 3D). Certain
amino acids often accumulate in the medium during batch growth with surplus glucose
and glutamine [55]. This may be due to a strong overflow metabolism originating from
high concentrations of AAs. Indeed, the Ala-Gln dipeptide (“Stable Glutamin” at the
concentration of 200 mM) added to our medium was split entirely very quickly into Ala
and Gln; this led to a rapid, significant increase of Ala and Gln concentration in the
medium (see Supplementary Materials Figure S9). Consequently, there is a large excess
of these two molecules in the cell culture medium, and hence, they are not considered
further in this analysis. On the other hand, glutamate and glycine are secreted in the
cell culture media regardless of the culture system used to grow the hASCs. The amino
acid consumption profile of hASCs cultured in dynamic 3D conditions is similar to that
obtained from traditional planar 2D cultures, and the mainly consumed are Ser and Cys.
Our data are qualitatively in good agreement with measurements of Schop et al. [56] and
Higuera et al. [57]. None of the AAs are exhausted, and the lowest concentration, that of
serine, still represents around 70% (for dynamic 3D) or 60% (for planar 2D) of the initial
concentration. Accordingly, growth inhibition by an amino acid is unlikely. Therefore, this
analysis suggests that the UrSuppe medium has a composition of amino acids sufficient
to sustain the growth of hASCs. The only surprising observation is represented by the
tryptophan level, which is higher in dynamic 3D set up than the planar 2D condition. We
have no explanation for this phenomenon, and we can only take note of it.
4. Discussion
Regenerative medicine needs new tools to obtain high cell numbers while preserving
the behavior of the cell. It is well known that intrinsic molecular mechanisms regulate the
fate of stem cells. However, many cell-external factors are also responsible for the overall
orchestration of stem cell activity. Especially, the ECM affects stem cell fate, with specific
relevance on ECM ligands’ interactions with cell surface receptors [56]. This ECM-based
control of the cell may also happen through various physical mechanisms: ECM geometry,
ECM elasticity, and mechanical signals conveyed from the ECM to the cell. Furthermore,
cells can sense micro- and nano-scale geometric stimuli from their surroundings, which may
occur in the form of differences in molecular conformation, for example, such as surface
topography, surface roughness, and fiber diameter [58]. The stiffness of the ECM may also
participate in lineage commitment, and this hypothesis was tested recently. Interestingly,
it turned out that a soft substrate reproducing the tissue niche could keep stem cells in a
quiescent status while safeguarding their “stemness” [58].
This study used the commercial non-biodegradable PNF MC as a “gold standard” and
positive control to evaluate the experiments’ outcomes. The BR44 and PNF MCs’ stiffness
and permeability are very different: PNF offers the cells a rigid and impermeable adhesion
surface, while BR44 is softer and more permeable since it is very porous. Thus, these two
MCs’ differences are attributable to their composition: resorbable biomaterial of natural
derivation (BR44) versus nondegradable synthetic material (PNF). MCs’ structure and
composition are essential as the adhesion substrate is one of the primary influencers of cell
expansion and differentiation. Furthermore, it is known that the stiffness of the substrate
where the cells grow can influence their cell differentiation [58,59]. Since the adipose tissue
can be considered as a soft environment, it may be possible that a soft adhesion surface
would favor hASCs growth. Therefore, it could be possible that a MC based on natural
biopolymers mimics the ECM properties (a reticulated porous shape and a soft structure,
like BR44) better, and hASCs benefit from this environment.
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Due to safety concerns and possible uncontrollable detrimental effects of FBS in clinical
applications [60–62], the BR44 MC was used in combination with a proprietary defined
xeno- and serum-free cell culture medium (UrSuppe) suitable for the dynamic cultivation
of hASCs in spinner flasks. We believe that developing the MC and the defined cell culture
medium simultaneously is an excellent strategy. Indeed, it has been recently shown that a
good performing serum-free medium is cell-specific and demands optimization for MC-
based dynamic cell culture systems [18]. The tissue cells, under normal conditions, are
never in direct contact with the serum. The only ones that are constantly so are blood
and endothelium cells. Therefore, the tissue cells are surrounded by the interstitial fluid,
which contains fewer proteins than serum and is specific for every tissue or organ. This is
because each interstitial fluid is formed by the tissue’s secretion products with which it
is in contact and therefore acquires a particular blend of secreted proteins and metabolic
molecules [63,64]. Therefore, a serum-free medium tries to mimic and reproduce an
interstitial fluid specific for a particular type of tissue cell.
Cells are usually organized in complex 3D structures and are subjected to movements:
fluids flow between the cells, tissue contractions or movements are not uncommon, and
motor activities are widespread actions in the animal kingdom. Thus, it may be possible that
the conditions created in a stirred flask or agitated bioreactor somehow better reproduce
the natural situation familiar for the cells in the body. Therefore, a dynamic 3D cell culture
system combined with a defined cell culture media may mimic better the natural cells’
environment allowing hASCs to proliferate and maintain their undifferentiated status.
This study was also instrumental in understanding the drawbacks of biodegrad-
able microcarriers compared to traditional ones that are not bioerodible. Indeed, we
noticed that BR44 MC is more challenging to handle than its synthetic counterparts. The
biodegradable MC easily sticks to pipettes and other equipment commonly used in the
laboratory. However, this peculiarity also characterizes other MCs made from organic or
biological polymers, such as Cultisphere S and G, Cytodex 3, and Celnest Macroporous
MCs (Fujifilm).
This intrinsic predisposition to stick together is also maintained in culture with cells by
this type of MCs. Thus, even under dynamic conditions, this can result in the formation of
large aggregates. Therefore, it is necessary to fine-tune the stirring conditions to minimalize
this phenomenon, which could cause a decrease in cell density due to limiting diffusion
of nutrients to the center of large cell-MC clusters. Therefore, MCs manufactured with a
biopolymer may need a more laborious setup regarding the seeding densities and agitation
parameters than classic synthetic MCs. This observation suggests that perhaps stirred tank
bioreactor may not be the most suitable system for growing hASCs when biodegradable
MCs are used. Therefore, it will be interesting to test other types of reactors that may
better adapt to biodegradable MCs’ peculiarities [65]. As an alternative, there would be
the possibility of culturing hASCs without scaffolds, in suspension, in the form of cell
aggregates or spheroids [66,67]. This cell culture technique is starting to give encouraging
results, but it is unlikely that it will work for all types of primary (stem) cells. Moreover, it
will be challenging to reach such high expansion factors with this technique, as in cultures
based on MC.
A comparison of the obtained growth-related parameters of this proof-of-concept
study with literature data clearly showed the suitability of the BR44 MC for the in vitro
expansion of hASCs (see Table S11 in the Supplementary Materials). As for different
non-biodegradable MCs in serum-free media, comparable data were achieved at a small
scale [21,23,68,69]. However, it is clear that further investigations, especially in larger
bioreactor systems, are required to improve the process performance with BR44 MC
further. This is particularly important in optimizing the MC suspension properties (i.e.,
MC concentration, cell-to-bead ratio) to increase the total cell yield to achieve clinically
relevant cell numbers in fully automated and instrumented bioreactor systems.
The growth rate is not the only parameter that is important in the cell culture process.
A crucial feature for a stem cell culture platform is its ability to “seal” the cells’ undiffer-
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entiated status during the in vitro amplification phase. Therefore, it was imperative to
verify by flow cytometry whether the hASCs growing on BR44 MC expressed the same
standard surface markers and maintained an immature status as the same batch of cells
expanded in traditional cell culture vessels (2D conditions). Interestingly, this analysis
highlighted some notable deviations between cells grown in 2D from those grown in 3D
on BR44 MC or PNF MC in static conditions. First, CD105 expression was significantly
reduced when hASCs were grown on PNF MC. We believe that this effect is mediated by
the composition of the different materials that form the two different MCs. However, the
downregulation of CD105 in hASCs grown on PNF MCs does not automatically mean that
the cells are no longer usable for cell therapies, as reported by Liem Hieu Pham et al. [70].
Secondly, the reduction of CD146 expression on cells grown on MC was intriguing. This
surface protein is also referred to as melanoma cell adhesion molecule (MCAM). CD146
occurs with two transmembrane isoforms and a soluble protein detectable in the plasma.
The traditional role attributed to it is to participate in intracellular adhesion. However,
CD146 mediates pleiotropic tasks through homophilic and heterophilic interactions with
polypeptides present in the surroundings [71,72]. Several reports suggested that CD146
may be linked with many nonresolving inflammatory diseases [73,74]. It was also de-
scribed on the surface of activated inflammatory cells [75,76]. Yongting Luo et al. found
that macrophagic CD146 promotes foam cell formation and interacts with CD36 to mediate
oxidized low-density lipoprotein (oxLDL) uptake [77]. Consequently, it is not surprising
that CD146 was also associated with adipogenic differentiation. Indeed, Graham G. Walms-
ley et al. showed that hASCs induced to differentiate into adipocytes expressed the CD146
as well as the CD36 marker [24]. This latter also marks adipocyte progenitors with pro-
nounced adipogenic potential and triglycerides storage ability and plays a functional role
in adipogenesis [27,28,78]. Indeed, CD36 expression was upregulated when hASCs start to
differentiate into adipocytes [24], and it was strongly expressed by mature adipocytes [26].
Its expression is also upregulated in a wide range of cell and tissue types by various senes-
cent stimuli [79]. For these reasons, we consider the presence of CD36 on hASCs as a label
of loss of the undifferentiated status and ongoing adipogenesis. Finally, we confirmed that
CD36 and CD146 could be coexpressed on early adipocytes, as shown in the Supplementary
Materials Figure S5. The low expression of CD15 or CD34 observed is also an excellent
feature of the hASCs grown in UrSuppe medium, which signalize being mostly immature
cells. CD15, also known as Sialyl LewisX (sLeX) or stage-specific embryonic antigen 1
(SSEA-1), is a tetrasaccharide carbohydrate commonly linked to O-glycans on the surface
of cells. Experiments gave this surface marker a role in cell adhesion and the regulation of
cell differentiation [80]. Remarkably, its expression pattern is different from humans and
mice. Indeed, in mice, it is present on embryonic stem cells (ES), embryonal carcinoma cells
(EC), 8-cell to blastocyst embryos, a subset of embryonic inner cell mass, and it disappears
upon differentiation. However, in humans, CD15 is not detected on undifferentiated ES
cells, but its transcription is upregulated along with differentiation [81,82]. CD15 is highly
expressed in adult human granulocytes. The transmembrane phosphoglycoprotein CD34
was first characterized as a hematopoietic stem cell marker but was later found on several
nonhematopoietic cell types [83]. This marker is associated with selecting and enriching
stem cells for bone marrow transplants in the clinic. Freshly extracted hASCs are CD34+,
but they lose this marker upon plastic adhesion and culture [84]. In the adipose tissue,
CD34 is expressed on the surface of mature adipocytes [26], and it is upregulated when
hASCs are induced to mature toward an adipogenic lineage [24,85]. These data suggest
that CD34, at least in the adipose tissue, does not signal “stemness” but rather a marker of
adipogenic differentiation expressed by early and mature adipocytes.
Similar to flow cytometry, we used RT-qPCR to monitor stemness or differentiation-
related genes. The hASCs used during this project were obtained from subcutaneous
adipose tissue. Thus, we expected that the default differentiation pathway of these cells,
in case of spontaneous maturation in vitro, was towards the tissue from which they were
purified. Adipogenesis is a complex and multistage process through which precursor
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cells differentiate into mature adipocytes, coordinated by signaling interchanges among a
myriad of different complex molecular systems [41]. Some of the genes that orchestrate
this process by inducing or repressing adipogenesis are known and are schematically
represented in Figure S7 and Tables S7 and S8 in the Supplementary Materials. Even with
these experiments, we found that 3D conditions did not compromise the cells’ undiffer-
entiated status. On the contrary, in several respects, it appeared even superior to that of
hASCs grown in standard 2D cell culture vessels. These experiments proved again that
the substrate on which the cells were cultured could modulate some genes’ expression, as
observed with the flow cytometry analysis.
Since some polypeptides are secreted only at particular stages of development or mat-
uration, they may be of diagnostic value in revealing a specific metabolic state or a specific
degree of cell differentiation. One of the earliest changes seen in adipocyte differentiation
is the biogenesis of the basement membrane. Nidogen/Entactin is an excellent marker to
signalize ongoing adipogenesis [86]. Therefore, this protein’s low expression level, together
with the lack of adiponectin and leptin, proves that most cells stayed undifferentiated and
immature in the dynamic 3D cell culture system. Next, we noticed the presence of two
Cathepsin family members. These polypeptides are proteases that are involved in crucial
mammalian cellular turnover. Cathepsin D [87] (aspartyl protease) and Cathepsin L [88]
(cysteine protease) play essential physiological roles in the adipose tissue and are essential
for remodeling the extracellular matrix (ECM) [89] during adipogenesis. Interestingly,
Cathepsin D also has mitogenic activity independent of its proteolytic activity, and its
knock-out in mice revealed that it is indispensable for postnatal tissue homeostasis [90].
Therefore, the presence of these proteins in the supernatants is not surprising, and there
are no relevant differences between the three cell culture systems considered in our study.
However, these proteases are considered to be promoters of adipogenesis [87,88]. The next
group of related polypeptides consists of the Insulin-like growth factor-binding proteins
(IGFBPs). One of their primary function is to fine-tune Insulin-like growth factors (IGF-I
and IGF-II) action by regulating the accessibility of these peptide hormones to their recep-
tors [91]. Both IGF-I [92] and IGF-II [93,94] are proadipogenic. It has been reported that
IGFBP-4 interacts with IGF-I and its presence negatively correlates with adipose tissue
growth [95]. IGFBP-6 can bind IGF-II and IGFBP-7 both, IGF-I and II [96]. Thus, it is
likely that these three members of the IGFBP family are antiadipogenic. However, IGFBP-6
secretion decreased in the dynamic 3D conditions with BR44 MC, and this could be an
unfavorable trend. Nevertheless, since it does not serve to sequester IGF-II as this proadi-
pogenic growth factor is not present in the UrSuppe medium, its decrease should not affect
the undifferentiated status of the hASCs. Furthermore, another member of the family,
IGFBP-7, remains well expressed in the dynamic 3D conditions and may compensate
for the decrease of IGFBP-6. IGFBP-7, also called Angiomodulin (AGM), is a particular
member of this family. It is a secreted polypeptide kept in Weibel-Palade granules and
produced by the developing vasculature [97]. It can also bind chemokines and growth
factors, including VEGF-A [98,99]. Therefore, IGFBP-7 is now considered proangiogenic
in the developing vasculature, that in combination with VEGF-A and presumably other
angiogenic factors, it guides and stabilizes the nascent vasculature. The data collected so
far support a model wherein IGPBP-7 may serve as biochemical growth factors storage by
providing an extracellular scaffold to which VEGF-A and other proteins could be deposited
within the ECM milieu, resulting in the proper downstream signaling and fine-tuning
of critical biological processes, such as angiogenesis [100]. Taken together, the secretion
profile of IGFBPs family members appears to be favorable to maintaining “juvenile” hASCs.
Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that controls
proinflammatory response and is linked with numerous inflammatory and autoimmune
diseases [101]. During adipogenesis, the role of MIF was studied by Atsumi et al. and
found to be antiadipogenic [102]. This finding agrees with the known ability of MIF to
counter-regulate the immunosuppressive effects of glucocorticoids [103], which are also
well known for their capacity to induce adipocyte maturation. Interestingly, this factor’s
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expression was higher in the samples where the cells were grown in both 3D conditions.
ECM remodeling marks out the onset of the differentiation during adipogenesis: type I and
III collagen, fibronectin, and β1-integrins are downregulated, whereas type IV collagen
and nidogen-1/entactin are upregulated. This guided turnover of the ECM is orchestrated
by matrix metalloproteases (MMP) and by tissue inhibitors of metalloproteases (TIMP),
which control the proteases’ enzymatic activity [86]. TIMP-1 was the first described natural
collagenase inhibitor. However, later it was shown that TIMP-1 is a negative regulator of
adipogenesis [104,105]. Surprisingly, it was also discovered that TIMPs function also as
signaling molecules with cytokine-like activities, thus playing important roles in various
biological processes, such as cell growth, apoptosis, differentiation, angiogenesis, and
oncogenesis. All these functions are independent of MMP inhibition [106,107]. Therefore,
TIMP-1 is a molecule with a biological significance not to be underestimated and not just
a protease inhibitor. From our perspective, if the secretion of an antiadipogenic factor
increases in 3D dynamic conditions compared to the static 2D or 3D system, we consider it
a positive event since it could be helpful to keep hASCs undifferentiated. The increase of
TIMP-1 in the dynamic 3D condition is therefore considered positively. In summary, these
results indicate that the secretion profile can be modulated depending on the cultivation
system (standard static 2D vs. static 3D vs. dynamic 3D). The commercially available
“Proteome Profiler Human Adipokine Array” we used for our study detects up to 58
adipose tissue-related molecules; however, we only found 16. We think that this result may
denote that the cells cultured with the three different systems remain immature, and their
relatively simple secretome manifests this undifferentiated status. We wanted to verify,
with a technique different from flow cytometry or RT-qPCR, whether hASCs grown in
dynamic 3D conditions maintained their undifferentiated status at least as much as those
grown in a standard 2D cell culture system. This seems the case since the secretion profiles
are similar.
In recent years, it has been realized that many nutrients and intermediates of energy
metabolism are not only carriers of energy. They also function as molecular mediators
by activating specific receptors that fine-tune metabolic pathways, immune and cellular
signaling, and cell fate’s epigenetic regulation [108,109]. Different cell states need specific
metabolic programs to sustain the distinct bioenergetic demands underlying their spe-
cialized functions. Amino acids (AAs) are also essential as regulators of fluxes through
major metabolic pathways [110,111]. The amino acid consumption profiles we recorded
by analyzing the supernatants fell qualitatively in with measurements of Schop et al. [56]
and Higuera et al. [57]. However, there was one intriguing surprise: The tryptophan
concentration was higher in dynamic 3D set up than in planar 2D condition. A recent
study has shown that the tryptophan metabolism in mesenchymal stem cells modulates
inflammation by suppressing leukocytes’ activation [112,113]. It could be possible that the
dynamic 3D arrangement promotes the secretion of this amino acid that then contributes to
the anti-inflammatory effect seen in previous experiments. Interestingly, Higuera et al. [57]
observed a similar phenomenon using bone marrow-derived MSCs and comparing amino
acid consumption between static and dynamic cell culture systems. Indeed, it was found
that cysteine and proline are produced by bone marrow-derived MSCs in static while
consumed under dynamic culture conditions. These data suggest that the static vs. dy-
namic mechanical treatment of cells grown with the same medium and conditions can also
influence some amino acid consumption or production.
Cell culture is a young science that has its origins in pioneering studies that began
around 120 years ago [114]. Even today, it still relies on the use of indefinite culture
media containing FBS and 2D static conditions based on polystyrene cell culture vessels.
However, about 40 years ago, the need to have cells that produce large quantities of
therapeutic biomolecules made it necessary to introduce new techniques, such as defined
xeno- and serum-free media, microcarriers, and different types of bioreactors to culture
them. Recently, the idea of using cells for regenerative and cosmetic medicine, or cellular
agriculture, has enormously boosted the interest in these technologies. Unfortunately,
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our knowledge of these new processes is still limited. Indeed, we still rely heavily on
procedures and knowledge related to traditional static 2D techniques combined with
undefined FBS-based culture media. Therefore, our primary concern in this feasibility
study was to verify whether primary hASCs grew on BR44 MC under defined dynamic
conditions, maintaining features close to those grown in static 2D cell culture vessels, which
is the system we know best and is the primary reference for all laboratories worldwide.
We tested more than 50 microcarrier prototypes over 2 years before deciding to complete
the study with the BR44 MC. Simultaneously, we developed the cell culture medium we
called UrSuppe.
In conclusion, our data suggest that hASCs cultured on BR44 MCs in xeno- and
serum-free medium under dynamic conditions do not degenerate and maintain similar
characteristics to those grown in traditional static 2D systems. Surprisingly, hASCs pre-
served their undifferentiated status better regarding some molecular markers and were
less inflammation-prone in dynamic 3D conditions than in the static 2D setup. This means
that the most advanced dynamic 3D cell culture technologies can be employed to mass
expand hASCs for future cell therapies. Furthermore, the UrSuppe medium could prove
very useful for studying ex vivo human adipocytes’ biology and their precursors under
defined cell culture conditions.
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